Incidence and Prognostic Value of DELIRIUM in Patients With Acute CORonary synDrome: an observatIonal Study
- Conditions
- DeliriumAcute Coronary Syndrome
- Registration Number
- NCT02004665
- Lead Sponsor
- Ospedale San Donato
- Brief Summary
to evaluate the incidence of delirium in patients with acute coronary syndrome and its correlation with adverse events
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
- acute coronary syndrome patients undergone coronary revascularization or referred to conservative strategy
- age ≥ 70 years
- diagnosis of delirium by the Confusion Assessment Method in the ICU (CAM-ICU) scale
Exclusion Criteria
- none
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method in-hospital adverse events incidence until discharge (4-7 days from admission)
- Secondary Outcome Measures
Name Time Method 12-month adverse events incidence 12 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link delirium to adverse outcomes in acute coronary syndrome patients?
Are there specific biomarkers that predict delirium risk in acute coronary syndrome populations?
How does delirium incidence in acute coronary syndrome compare to other post-cardiac event complications?
What are the potential neuroinflammatory pathways contributing to delirium in acute coronary syndrome?
What management strategies reduce delirium-related adverse events in acute coronary syndrome patients?
Trial Locations
- Locations (1)
Cardiovascular Department, Ospedale S.Donato
🇮🇹Arezzo, AR, Italy
Cardiovascular Department, Ospedale S.Donato🇮🇹Arezzo, AR, ItalyGiovanni Falsini, MDPrincipal InvestigatorLeonardo Bolognese, MD, FESCPrincipal Investigator